Genome Canada

What Genome Canada does

Genome Canada is a federally funded, Ottawa-headquartered not-for-profit organization founded in 2000 that operates as the designated national leader for Canada's genomics ecosystem. The organization does not sell commercial products; rather, it funds and coordinates large-scale genomics research and commercialization across multiple sectors, deploying federal appropriations and catalyzing private and academic co-investment through programs such as the Genomic Applications Partnership Program (GAPP), the Canadian Precision Health Initiative (CPHI, targeting 100,000 genomes), the Pan-Canadian Genome Library (PCGL), Climate-Smart Agriculture and Food Systems, All for One (rare disease genomics), and CanCOGeN (pathogen surveillance).

Its core technology and product surface consists of funded platforms and infrastructure rather than proprietary software: SmartRequisition (an AI-assisted genomic test requisition workflow automation platform), the Pan-Canadian Human Genome Library (centralized federated data management), the Indigenous Variant Biovault Library (Indigenous-managed genomic reference data), ClarityDX Prostate (AI-powered blood-based biomarker diagnostic), metapipeline-DNA (Nextflow-based computational pipeline), and Dualase® gene editing (ML-accelerated editor prediction). These are developed by grantees and partners including PhenoTips, Specific Biologics, Axolotl Biosciences, McGill University, Western University, and UBC, with Genome Canada providing capital and coordination.

Its business model is structured as a federally appropriated, mission-driven funding and ecosystem-coordination entity with no commercial revenue stream. Capital flows in primarily through Government of Canada appropriations (including the $175.1M Canadian Genomics Strategy over seven years), with co-investment from industry and academic partners (e.g., $45M+ catalyzed from a $20M federal announcement). Distribution is executed through a federated pan-Canadian network of six regional Genome Centres — Genome BC, Genome Alberta, Genome Prairie, Ontario Genomics, Génome Québec, and Genome Atlantic — collectively branded as the Canadian Genomics Enterprise. Customer segments served include health and healthcare (primary), agriculture and food systems, climate change and environment, Indigenous communities, and the broader Canadian biotechnology industry. Since 2000, the organization has facilitated over $4B in research investment, supported 15,000 research team members, generated 131 spinoff companies, and produced 531 patents, licenses, and inventions.

Name

Genome Canada

Legal name

Génome Canada

Website

https://genomecanada.ca

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Genome Canada is a federally funded, Ottawa-headquartered not-for-profit founded in 2000 that coordinates Canada's genomics ecosystem through a federated network of six regional Genome Centres, deploying federal appropriations and catalyzing private co-investment to fund genomics research, AI-enabled commercialization, and national data infrastructure across health, agriculture, and environment sectors.

Ownership category

akta.pro rank

Product category

Genomics Research Funding and Coordination

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)

akta.pro secondary industries

Public Health Genomics & Sequencing (WGS/Metagenomics) Networks (HLAJAIAK), Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Digital Breeding & Bioinformatics Software (Breeding informatics, decision tools) (AFABALAL)

Keywords

• Genomics research funding
• National genomics coordination
• Biotechnology commercialization programs
• Precision health initiatives
• Genomic data infrastructure

Headquarters

HQ city

Ottawa

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Federal Government Appropriations: Genome Canada is a not-for-profit organization primarily funded through federal government appropriations. Funding supports large-scale genomics research, commercialization programs (GAPP), data coordination, and talent development under the Canadian Genomics Strategy.
2. Co-Investment from Industry and Academic Partners: Industry and academic co-investment in GAPP-funded projects. Federal investment catalyzes private and public co-investment—for example, the $20M federal announcement generated over $45M in additional co-investment. Industry partners provide capital, in-kind contributions, and commercialization expertise.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Genome Canada is a federally funded not-for-profit organization that invests in and coordinates large-scale genomics research and its translation into applications across health, agriculture, climate/environment, and biotechnology sectors. Through programs like the Genomic Applications Partnership Program (GAPP), the Canadian Precision Health Initiative (CPHI), CanCOGeN, Climate-Smart Agriculture, and All for One, it distributes grants, catalyzes private co-investment, and convenes a federated network of six regional Genome Centres to accelerate commercialization of genomics-driven innovation.

Product overview

Genome Canada operates as a national not-for-profit organization that funds and coordinates genomics research across Canada rather than selling commercial products. Its portfolio includes the Canadian Precision Health Initiative (CPHI) for precision medicine with 100,000 genomes, the Pan-Canadian Human Genome Library for data management, SmartRequisition AI platform for automating genomic test workflows, and the Genomic Applications Partnership Program (GAPP) for commercializing genomics innovations. Additional initiatives include CanCOGeN for pathogen surveillance, Climate-Smart Agriculture and Food Systems, and All for One for rare diseases. The organization connects academic researchers with industry partners through regional Genome Centres to translate genomics research into health, agricultural, and environmental solutions.

Differentiator

Problem solved

Functional benefit

Brands

• Canadian Precision Health Initiative (CPHI): National initiative to sequence 100,000 genomes for more personalized, effective healthcare
• Genomic Applications Partnership Program (GAPP)
• Canadian COVID-19 Genomics Network (CanCOGeN)
• Climate-Smart Agriculture and Food Systems
• All for One
• Canadian Genomics Enterprise

Products and services

• Genomic Applications Partnership Program (GAPP) Flagship commercialization funding initiative supporting collaborations between Canadian for-profit companies and academic researchers to advance genomics-driven innovation. National stream provides up to $2 million per project plus regional streams for earlier-stage projects typically $300,000 to over $1M. Open to Canadian biotech companies, academic researchers, and industry partners across health, agriculture, and industrial applications.
• Canadian Precision Health Initiative (CPHI) National initiative to sequence 100,000 Canadians' genomes to build a dataset for advancing precision medicine across Canada's healthcare system. Open to Canadian healthcare institutions, clinical laboratories, and research partners seeking to advance precision medicine.
• CanCOGeN (Canadian COVID-19 Genomics Network) Canadian COVID-19 genomics network for pathogen surveillance including VirusSeq and HostSeq components for virus and host genomic monitoring. Open to public health authorities, researchers, and clinical institutions participating in pathogen surveillance.
• Climate-Smart Agriculture and Food Systems Initiative Initiative focused on developing climate-resilient food systems through genomics research in agriculture. Open to Canadian agri-food companies, academic researchers, and food technology startups.
• All for One Initiative Initiative focused on rare disease research and genomic medicine access across Canada. Open to Canadian rare disease researchers, clinical institutions, and patient advocacy organizations.
• Pan-Canadian Human Genome Library (PCHGL) Centralized and federated data management system for human genomic data that unifies Canada's human genome sequencing efforts and enables long-term archival, data discovery and controlled access. Open to Canadian researchers, clinical institutions, and academic partners requiring national genomic data infrastructure.
• SmartRequisition (CIPHER Network) AI-assisted platform that automates genomic test requisition workflows, enabling non-genetics specialists to order genetic tests using standardized vocabulary. Part of the CIPHER network initiative bringing together five Canadian health institutions. Targets acceleration of diagnoses for over 10,000 Canadians annually.
• Indigenous Variant Biovault Library (IVBL) Indigenous-managed component of the Pan-Canadian Genome Library providing Indigenous genomic reference data to improve diagnosis and support research for First Nations, Inuit, and Métis communities. Operates under OCAP (Ownership, Control, Access and Possession) principles for Indigenous data sovereignty.

Quantifiable outcome

• $4B in total research investment facilitated since 2000
• +5 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature5 records

Partnerships

14 partnerships are on record, tiered core and minor.

• LifeLabscoreStrategic or Co-development Partner · 1 June 2026LifeLabs partnered with UBC's MOSAIC research team to advance cardiovascular health care in British Columbia using advanced heart imaging, genomics, and AI. LifeLabs provides sample collection through its network of 129 patient service centres, enabling participation for residents including those in rural and remote communities. The initiative is part of the Canadian Precision Health Initiative, funded by Genome Canada and Genome BC.
• Confederacy of Mainland Mi'kmaqcoreStrategic or Co-development Partner · 1 May 2026The Confederacy of Mainland Mi'kmaq leads a community-driven microbe sequencing and naming project at Pictou Landing First Nation in Nova Scotia, funded through Genome Atlantic and Genome Canada's Indigenous Genomics Training and Capacity Program ($420,000 federal plus $116,738 co-funding). Community members from elementary students to Mi'kmaw Elders participate in sequencing micro-organisms from local marine sediments, integrating Indigenous knowledge with genomic science.
• One Yukon CoalitioncoreStrategic or Co-development Partner · 1 May 2026The One Yukon Coalition leads an Indigenous-led genomics curriculum project for One Health and climate resilience in the North, funded by Genome British Columbia and Genome Canada's Indigenous Genomics Training and Capacity Program. The project trains at least 40 Indigenous participants in eDNA sampling, wastewater monitoring, and genomic analysis, developing a micro-credentialed curriculum scalable to other Northern, rural, and Indigenous communities.
• Université LavalcoreStrategic or Co-development Partner · 1 April 2026Université Laval partnered with Aplantex on a $2.2M joint research project—one of six funded by Genome Canada and Génome Québec—to develop a high-throughput platform combining AI, genetic transformation, and hyperspectral imaging for accelerated selection of high-yielding plant clonal lines for cosmetics, nutraceuticals, agri-food, and biopharmaceutical industries.
• PhenoTipscoreStrategic or Co-development Partner · 1 March 2026PhenoTips co-led the $5.4M SmartRequisition national AI initiative (CIPHER network) with five Canadian health institutions, funded by Genome Canada ($1.8M). The AI-assisted platform automates genomic test requisition workflows, enabling non-genetics specialists to order genetic tests using standardized vocabulary, targeting acceleration of diagnoses for over 10,000 Canadians annually.
• Western UniversitycoreStrategic or Co-development Partner · 1 March 2026Western University partnered with Specific Biologics Inc. on a CAD$1.8M Genome Canada and Ontario Genomics grant to develop a machine learning-enabled prediction platform for Dualase® genome editors. Research team led by Dr. David Edgell integrates large-scale genomic datasets and structural modeling to identify potent editors for C9ORF72 ALS, Huntington's Disease, and other repeat expansion disorders.
• Axolotl BiosciencescoreStrategic or Co-development PartnerAxolotl Biosciences (Victoria, BC) partnered with UBC's Dr. Zachary Laksman on the HeartPrint project using genomics-informed bio-inks to 3D-print heart tissue for disease modeling and drug testing. The initiative aims to pave the way for safer, more personalized cardiovascular treatments, funded through Genome Canada's Canadian Genomics Strategy.
• Sanford Burnham Prebys Medical Discovery InstituteminorStrategic or Co-development PartnerScientists from Sanford Burnham Prebys and UCLA developed metapipeline-DNA, a computational pipeline to standardize and automate large-scale genome sequencing data processing using Nextflow workflow management, reducing custom scripting needs and improving reproducibility across research environments. Validated against cancer genomics datasets.
• Genome British Columbia (Genome BC)coreStrategic or Co-development PartnerRegional Genome Centre covering British Columbia. Part of the Canadian Genomics Enterprise—Genome Canada's federated national network of six regional Genome Centres. Co-funds GAPP projects with Genome Canada (up to $1M additional), funds Indigenous genomics projects, and partners on Canadian Precision Health Initiative.
• Genome AlbertacoreStrategic or Co-development PartnerRegional Genome Centre covering Alberta. Part of the Canadian Genomics Enterprise delivering GAPP and other genomics programs in Alberta, supporting industry-academic collaborations and Alberta's life sciences sector.
• Genome PrairiecoreStrategic or Co-development PartnerRegional Genome Centre covering Manitoba and Saskatchewan. Part of the Canadian Genomics Enterprise delivering GAPP and other genomics programs, translating research into market-ready technologies in the Prairie region.
• Ontario GenomicscoreStrategic or Co-development PartnerRegional Genome Centre covering Ontario. Part of the Canadian Genomics Enterprise, co-funding GAPP projects (including $1.8M Specific Biologics/Western Dualase grant) and delivering Ontario-specific genomics programs for health, agriculture, and industry.
• Génome QuébeccoreStrategic or Co-development PartnerRegional Genome Centre covering Quebec. Part of the Canadian Genomics Enterprise, co-funding GAPP projects (including $2.2M Aplantex/Université Laval project) and supporting Quebec's genomics ecosystem for health, agriculture, and biotechnology.
• Genome AtlanticcoreStrategic or Co-development PartnerRegional Genome Centre covering Atlantic Canada (Nova Scotia, New Brunswick, Prince Edward Island, Newfoundland and Labrador). Part of the Canadian Genomics Enterprise, supporting industry-led genomics projects across energy, agriculture, synthetic biology, and health—including the $1M+ Triple Point Resources collaboration with University of Calgary and Memorial University.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• National Institutes of Health (NIH): The largest biomedical research funder in the world. NIH is comparable to Genome Canada as a public-sector genomics and health research funding agency, though it operates at vastly larger scale and is the closest global analogue for Genome Canada's national convenor role.
• Wellcome Trust: A UK-based charitable foundation funding health and genomics research globally. Comparable to Genome Canada in mission-driven approach, large-scale research portfolio, and ecosystem coordination role, though Wellcome is significantly larger and has independent endowment funding rather than federal appropriations.
• Commonwealth Scientific and Industrial Research Organisation (CSIRO): Australia's national science agency and a federally funded research organization. Comparable to Genome Canada in operating as a publicly funded national science coordinator spanning multiple sectors, though CSIRO operates its own labs whereas Genome Canada funds through partners.
• National Science Foundation (NSF): US federal agency funding fundamental research across sciences including genomics. Comparable to Genome Canada in federally funded national research coordination role, though NSF covers all sciences whereas Genome Canada focuses specifically on genomics and its applications.
• Innovate UK: UK's innovation agency funding business-led R&D and commercialization. Comparable to Genome Canada in its commercialization-focused GAPP program — both bridge research and industry by co-funding translational projects with industry partners.

Direct peers

• UK Research and Innovation (UKRI) - Medical Research Council: UKRI/MRC is the UK's primary public funder of medical and genomics research. It is the most direct international peer to Genome Canada — comparable scale, federal/public funding model, mission-driven programs, and national coordination role over regional research organizations.
• Canadian Institutes of Health Research (CIHR): Canada's primary federal health research funder. Direct domestic peer to Genome Canada — multiple Genome Canada executives (CFO, Director of Finance) previously held senior roles at CIHR. Both organizations fund Canadian health research and partner on genomics initiatives like the Pan-Canadian Genome Library.
• European Molecular Biology Laboratory (EMBL): Intergovernmental research organization in molecular life sciences across Europe. Comparable to Genome Canada as a publicly funded, mission-driven genomics research coordinator operating across multiple countries/member states and providing shared data infrastructure and training.
• Natural Sciences and Engineering Research Council of Canada (NSERC): Canada's federal council funding natural sciences and engineering research. Direct domestic peer to Genome Canada within the Canadian Tri-Council system — both are federally funded research funders in Canada, and potential co-funders or collaborators on genomics-adjacent science.

Emerging players

• Howard Hughes Medical Institute (HHMI): A large US biomedical research organization supporting investigators and translational genomics. Comparable to Genome Canada in mission-driven science funding and ecosystem-building role, though HHMI operates its own labs and investigator programs rather than a federated national network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/genomecanada
• YouTubeyoutube.com/user/genomecanada
• Facebookfacebook.com/genomecanada
• LinkedInlinkedin.com/company/genome-canada

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries6 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genome Canada